Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page
- Check5 days agoChange DetectedReplaced the Taiwan site entry 'Tainan City, Taiwan, 70403' with 'Tainan, Taiwan, 70403'.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe new screenshot shows only minor cosmetic/UI adjustments to the Study Details page, with no changes to core data such as eligibility criteria, primary/secondary outcomes, enrollment, or location. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded an operational status notice and updated version to v3.2.0; removed the old version v3.1.0.SummaryDifference1%

- Check48 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.2%

- Check62 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of the 'Back to Top' link; no substantive content changes detected.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.